FDA Drug Recalls

Recalls / Class II

Class IID-1074-2019

Product

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Affected lot / code info
Lot #: PA217060A, Exp 05/2020

Why it was recalled

Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

Recalling firm

Firm
Jubilant Cadista Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
207 Kiley Dr, N/A, Salisbury, Maryland 21801-2249

Distribution

Quantity
12,960 bottles
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2019-03-29
FDA classified
2019-04-01
Posted by FDA
2019-04-10
Terminated
2019-09-20
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1074-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.